Earnings
CBIO
5.95
+2.59%
0.15
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
15.37M
61.50M
--
15.00M
--
--
0.00
--
--
--
4.20M
0.00
96.07M
2.23M
--
--
--
--
--
--
257.00K
2.49M
98.55M
--
4.28M
0.00
--
--
--
--
--
9.62M
--
--
--
15.00M
28.90M
0.00
--
--
--
1.32M
1.32M
30.22M
12.00K
326.81M
-258.52M
--
--
--
68.34M
68.34M
98.55M
FY 2018-12-31
31.21M
88.91M
--
--
--
--
0.00
--
--
--
3.81M
50.00K
123.99M
386.00K
--
--
--
--
--
--
543.00K
929.00K
124.92M
--
1.25M
0.00
--
--
--
--
--
3.54M
--
--
--
15.00K
4.80M
0.00
--
--
--
174.00K
174.00K
4.97M
12.00K
323.28M
-203.34M
--
--
--
119.94M
119.94M
124.92M
FY 2017-12-31
14.47M
17.97M
--
24.00K
--
--
0.00
--
--
--
1.31M
5.33M
39.11M
276.00K
--
--
--
--
--
--
128.00K
404.00K
39.51M
--
747.00K
5.08M
--
--
--
--
--
2.69M
--
--
--
219.00K
8.74M
0.00
--
--
--
0.00
0.00
8.74M
6000.00
204.26M
-173.49M
--
--
--
30.77M
30.77M
39.51M
FY 2016-12-31
10.26M
6.80M
--
31.00K
--
--
0.00
--
--
--
958.00K
19.47M
37.52M
444.00K
--
--
--
--
--
--
125.00K
569.00K
38.09M
--
837.00K
19.40M
--
--
--
--
--
1.40M
--
--
--
324.00K
21.96M
0.00
--
--
--
54.00K
54.00K
22.02M
1000.00
164.05M
-147.98M
--
--
--
16.07M
16.07M
38.09M
FY 2015-12-31
29.10M
3.40M
--
492.00K
--
--
0.00
--
--
--
1.78M
33.93M
68.70M
698.00K
--
--
--
--
--
--
125.00K
823.00K
69.52M
--
939.00K
33.74M
--
--
--
--
--
1.46M
--
--
--
1.61M
37.76M
0.00
--
--
--
340.00K
340.00K
38.10M
11.00K
162.45M
-131.04M
--
--
--
31.43M
31.43M
69.52M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CBIO latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Catalyst Biosciences recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.